Health Condition 1: C569- Malignant neoplasm of unspecifiedovary Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Sentinel node detection: Patients will receive injection of tracer (Tc99m Sulphur colloid 37mBq 1mL and methylene blue dye 1% 2mL) in the ovarian and infundibulopelvic ligaments ligamen
Sponsors
AIIMS Rishikesh
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stage I and II epithelial ovarian cancers Patients with suspicious ovarian masses planned for hysterectomy and or salpingo-oophorectomy
Exclusion criteria
Exclusion criteria: Signs of malignant spread to the abdominal cavity on pre-operative imaging Patients with allergies to the tracers Diagnosed with malignancy other than ovarian cancer Prior history of pelvic or para-aortic lymphadenectomy or lymph node sampling Suspicious lymph nodal involvement on imaging Pregnant or lactating patients Not willing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sentinel lymph node detection rate, False negative rate and accuracy of sentinel node biopsyTimepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events related with sentinel lymph node procedure (CTCAE version 5.0) and complete lymphadenectomyTimepoint: 18 months;Comparison of detection rate between the two tracers and in combinationTimepoint: 18 months;Identifying various sites of sentinel node locationTimepoint: 18 months | — |
Countries
India
Contacts
Public ContactAyush Heda
AIIMS Rishikesh
Outcome results
None listed